July 12, 2018
RICHLAND, Wash., July 12, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
July 9, 2018
RICHLAND, Wash., July 09, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
July 9, 2018
GammaTile Therapy is the Next Step in the Expansion of Cesium to Additional Markets
RICHLAND, Wash., July 09, 2018
June 19, 2018
No Change Expected to Recent Strategic Initiatives that Continue to Build Momentum
Richland, Wash., June 19, 2018 ...
June 5, 2018
Richland, Wash., June 05, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
May 30, 2018
IsoRay Continues to Support Innovative Techniques in Brain Cancer Treatment
RICHLAND, Wash., May 30, 2018 (GLOBE ...
May 16, 2018
Key Presentation on Prostate Cancer: “Survivor Debate: Low-Intermediate Risk Prostate Cancer” will Feature Noted ...
May 11, 2018
RICHLAND, Wash., May 11, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
May 3, 2018
Fifth Consecutive Quarter of Year-Over-Year Revenue Increases
RICHLAND, Wash., May 03, 2018 (GLOBE NEWSWIRE) -- ...
May 2, 2018
NEW YORK, NY, May 02, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company and ...
April 26, 2018
RICHLAND, Wash., April 26, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (the “Company”) (NYSE American: ISR), a medical ...
April 18, 2018
RICHLAND, Wash, April 18, 2018 (GLOBE NEWSWIRE) -- IsoRay, Inc. (NYSE American: ISR), a medical technology company ...
